David Huang (Walter and Eliza Hall Institute of Medical Research (WEHI), Melbourne, Australia)
Session information
Industry Session
IS1-8
Targeting BCL2 to treat hematological cancers
Fri. Oct 12, 2018 1:50 PM - 2:20 PM No.8 (Osaka International Convention Center, 10F 1002)
Chair: Harumi Mukai (Hepatology & Oncology, Medical Affairs, Medical, AbbVie GK)
Sponsor: AbbVie GK